View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Tislelizumab 200, Nasopharyngeal Carcinoma, maintenance
Protocol-ID: 2993 V1.0 (Mini), TISL200, Nasopharyngeal Ca, Erh.Indication(s)
- Nasopharyngeal Carcinoma; ICD-10 C11.8, C11.9, C11.-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 03.09.2025